Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:05:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-04-18T13:20:40.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as the condition and the Genetic and Rare Diseases Information Center as a new resource. Updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T20:17:52.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2; no visible changes to the study details are evident.
    Difference
    0.1%
    Check dated 2026-03-06T17:46:13.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Investigator list updated: Kannan Thanikachalam, MD added and Renuka Iyer removed. Page revised to version 3.4.2 on 2026-02-05.
    Difference
    0.3%
    Check dated 2026-02-13T03:16:41.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new page revision tag was added: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:25:25.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.